Benjamin Auspitz

Directeur/Membre du Conseil chez Symbiomix Therapeutics LLC

Profil

Benjamin A. Auspitz was the founder of Dimension Therapeutics, Inc., founded in 2013, where the title held was Chairman.
Current jobs include Director at Symbiomix Therapeutics LLC, Director at Meves Pharmaceuticals, Inc., Director at Modis Therapeutics, Inc., Director at Zero Point Five Therapeutics, Inc., and Managing Partner at Curie Bio Operations LLC starting in 2025.
Former jobs include Director-Therapeutic Area at CombinatoRx, Inc., Director at Precision BioSciences, Inc., Director at REGENXBIO, Inc., Independent Director at Ultragenyx Pharmaceutical, Inc., Director at Compass Therapeutics LLC, Director at Cogent Biosciences, Inc., Director at LigoCyte Pharmaceuticals, Inc., Director at Checkmate Pharmaceuticals, Inc., Director at Turnstone Biologics, Inc., Director at Orchard Therapeutics (Europe) Ltd. from 2016 to 2018, Director at Xilio Therapeutics, Inc., Consultant at Braun Consulting, Inc. in 2000, Consultant at Vertex Partners in 1997, and Partner at F-Prime, Inc. Education includes undergraduate degree from Harvard University.

Postes actifs de Benjamin Auspitz

Sociétés	Poste	Début
Symbiomix Therapeutics LLC	Directeur/Membre du Conseil	-
Modis Therapeutics, Inc.	Directeur/Membre du Conseil	-
Meves Pharmaceuticals, Inc.	Directeur/Membre du Conseil	-
Zero Point Five Therapeutics, Inc.	Directeur/Membre du Conseil	-
Curie Bio Operations LLC	Analyste en capital-investissement	01/01/2025

Anciens postes connus de Benjamin Auspitz

Sociétés	Poste	Fin
Orchard Therapeutics (Europe) Ltd.	Président	11/04/2018
REGENXBIO INC.	Directeur/Membre du Conseil	01/05/2015
LigoCyte Pharmaceuticals, Inc.	Directeur/Membre du Conseil	16/04/2014
Braun Consulting, Inc.	Corporate Officer/Principal	01/01/2000
░░░░░░ ░░░░░░░░	░░░░░░░░░ ░░░░░░░░░░░░░░░░░	░░░░░░░░░░